Prof. Dr. pharm. sci. Bart De Spiegeleer
Laboratory of Drug Quality & Registration (DruQuaR)
Ottergemsesteenweg 460, 9000 Ghent (Belgium)
Phone: + 32 (0)9 264.81.00 (secr. 81.01)
Email: Bart.DeSpiegeleer@UGent.be
Biography
Prof. Dr. De Spiegeleer received a Master degree in Pharmaceutical Sciences (1982) and a second degree in Teaching Education (1986) from Ghent University. He was a research fellow at the University of Manchester (UK) (1988). He also completed his Doctoral Degree in Pharmaceutical Sciences at Ghent University (1989) and followed the middle management programme at the Vlerick’s Management School (1993). Being an industrial pharmacist (1986), he is a registered qualified person for the release of pharmaceutical products as well as a responsible person for pharmaco-vigilance (2000) and pharmaceutical information (2000).
Previously, Prof. Dr. De Spiegeleer worked in the pharmaceutical industry as qualified person, QA-QC head, regulatory affairs, technical and R&D manager at Federa and Couvreur (1989-1994). He was the founder and general manager of HEA (now Pharmavize)(1994-2004). From 2004-2008, he worked part-time at Ghent University, and since October 2008 full-time.
Prof. Dr. De Spiegeleer’s work has appeared in numerous publications, meeting-abstracts and patents, including peer reviewed journals like Analytical Chemistry, Talanta, Analytical Chimica Acta, Journal of Nuclear Medicine, Journal of Pharmaceutical and Biomedical Analysis, Journal of Chromatography. He was one of the founders and Editor of Journal of Planar Chromatography (1988-1991) and serves currently as a referee for different international scientific journals.
Prof. Dr. De Spiegeleer also teaches Advanced Drug Analysis and Quality, Regulatory Affairs, Pharmaceutical management skills and the Integrated Bachelor Course, and in addition, he is an invited guest lecturer within the Ghent University as well as at the University of Brussels where he teaches regulatory drug quality aspects. He is a member of the Belgian Pharmacopoeial Commission, as well as of the Commission on the elaboration of technical monographs for pharmaceutical ingredients.